Following President Donald Trump’s January 21, 2025 Executive Order (EO) titled, “Ending Illegal Discrimination and Restoring Merit-Based Opportunity,” recent federal developments may impact how companies approach their review of existing diversity, equity, and inclusion (DEI)

Continue Reading President Trump’s DEI Executive Orders: Recent developments for employers to know


The US Food and Drug Administration (FDA) recently issued its draft guidance, Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations on January 7, 2025. The draft guidance provides insights on how FDA

Continue Reading FDA issues Artificial Intelligence-Enabled Device Software Functions draft guidance


Time is running out for Corporate Transparency Act (CTA) compliance. The law, which became effective on January 1, 2024, requires certain entities – or “reporting companies” – to disclose information about their beneficial ownership to

Continue Reading ‘Tis the season and past time for a ho-ho-hum approach to Corporate Transparency Act reporting deadline